Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:51 AM
Ignite Modification Date: 2025-12-24 @ 11:51 AM
NCT ID: NCT03690661
Eligibility Criteria: Inclusion Criteria: 1. parent/caregiver of an adolescent with a diagnosis of autism spectrum disorder (ASD), 2. parent/caregiver and adolescent with ASD both native English speakers, 3. adolescent with ASD aged between 10-18 years at pre-test, 4. adolescent has normal vision and hearing with correction as reported by caregiver, 5. adolescent is able to use a computer for the purposes of game play, 6. adolescent scores \< 80% correct (i.e., 0.5 SD less than Mean of typically developing adolescents) on online eye gaze screening task, 7. ASD diagnosis of adolescent confirmed via Parent-report SCQ and clinical interview with adolescent to assess DSM-V criteria (borderline cases also undergo ADI interview); 8. Full Scale IQ of adolescent determined to be between 70-130; 9. reading ability of adolescent determined to be at least a 2nd grade level; 10. adolescent is capable of cooperating with testing; 11. parent/caregiver and adolescent both consent/assent to participate in the research. Exclusion Criteria: 1. having seizures within the previous two years 2. no stable internet connection in the home 3. refusing to consent/assent to take part in the research 4. 18 and have a legal guardian, which prohibits them from legally consenting for themselves 5. 18 and cannot understand the consent as indicated by failing a quiz prior to signing the consent.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 10 Years
Maximum Age: 18 Years
Study: NCT03690661
Study Brief:
Protocol Section: NCT03690661